Literature DB >> 29036701

Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.

Holly K Hamilton1,2, Veronica B Perez3,4, Judith M Ford1,2, Brian J Roach5, Judith Jaeger6,7, Daniel H Mathalon1,2.   

Abstract

Mismatch negativity (MMN) and P300 event-related potential (ERP) reductions in schizophrenia (SZ) reflect preattentive and attention-mediated auditory processing deficits, respectively. Although both have been linked to cognitive deficits in SZ, their relative contributions to real-world functioning are unclear. We sought to determine the functional significance of disrupted auditory processing in SZ by examining MMN and P300 in typically disabled low-functioning patients and in patients with high levels of independent role functioning. MMN to auditory deviants and P300 to infrequent auditory target and nontarget novel stimuli were assessed in 20 high-functioning SZ patients (HF-SZ), 17 low-functioning patients (LF-SZ), and 35 healthy comparison (HC) subjects. There was a group effect on MMN and P300 amplitudes across stimulus types. MMN was significantly diminished in LF-SZ compared to HF-SZ and HC, and HF-SZ demonstrated comparable MMN to HC. In contrast, P300 was significantly reduced in both LF-SZ and HF-SZ compared to HC. Logistic regression suggested independent sensitivity of MMN to functioning in SZ over and above P300 measures. Neither MMN nor P300 were associated with positive or negative symptom severity. Results replicate MMN and P300 abnormalities in SZ, and also suggest that the neural mechanisms associated with the preattentive detection of auditory deviance are most compromised in patients with functional disability. MMN may index pathophysiological processes that are critical for optimal functioning in SZ.

Entities:  

Mesh:

Year:  2018        PMID: 29036701      PMCID: PMC5890465          DOI: 10.1093/schbul/sbx104

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  110 in total

1.  The multidimensional scale of independent functioning: a new instrument for measuring functional disability in psychiatric populations.

Authors:  Judith Jaeger; Stefanie M Berns; Pál Czobor
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 2.  Memory-based or afferent processes in mismatch negativity (MMN): a review of the evidence.

Authors:  Risto Näätänen; Thomas Jacobsen; István Winkler
Journal:  Psychophysiology       Date:  2005-01       Impact factor: 4.016

3.  A triarchic model of P300 amplitude.

Authors:  R Johnson
Journal:  Psychophysiology       Date:  1986-07       Impact factor: 4.016

4.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

5.  Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

Authors:  Tamara Friedman; Pejman Sehatpour; Elisa Dias; Megan Perrin; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2011-12-21       Impact factor: 13.382

6.  Effect of ketamine on the neuromagnetic mismatch field in healthy humans.

Authors:  I Kreitschmann-Andermahr; T Rosburg; U Demme; E Gaser; H Nowak; H Sauer
Journal:  Brain Res Cogn Brain Res       Date:  2001-08

7.  Effects of risperidone on auditory event-related potentials in schizophrenia.

Authors:  Daniel Umbricht; Daniel Javitt; Gerald Novak; John Bates; Simcha Pollack; Jeffrey Lieberman; John Kane
Journal:  Int J Neuropsychopharmacol       Date:  1999-12       Impact factor: 5.176

8.  Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder.

Authors:  Daniel H Mathalon; Ralph E Hoffman; Todd D Watson; Ryan M Miller; Brian J Roach; Judith M Ford
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

9.  Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.

Authors:  Dean F Salisbury; Noriomi Kuroki; Kiyoto Kasai; Martha E Shenton; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2007-05

10.  P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.

Authors:  K L Coburn; S D Shillcutt; K A Tucker; K M Estes; F B Brin; P Merai; N C Moore
Journal:  Biol Psychiatry       Date:  1998-09-15       Impact factor: 13.382

View more
  14 in total

1.  Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.

Authors:  Holly K Hamilton; Deepak C D'Souza; Judith M Ford; Brian J Roach; Naomi S Kort; Kyung-Heup Ahn; Savita Bhakta; Mohini Ranganathan; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2017-07-12       Impact factor: 4.939

Review 2.  Language as a biomarker for psychosis: A natural language processing approach.

Authors:  Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff
Journal:  Schizophr Res       Date:  2020-06-01       Impact factor: 4.939

3.  A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.

Authors:  Caitlin K Monaghan; Sophie Brickman; Polly Huynh; Dost Öngür; Mei-Hua Hall
Journal:  Int J Psychophysiol       Date:  2019-05-17       Impact factor: 2.997

4.  Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.

Authors:  Holly K Hamilton; Scott W Woods; Brian J Roach; Katiah Llerena; Thomas H McGlashan; Vinod H Srihari; Judith M Ford; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

5.  Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication.

Authors:  Caitlyn Kruiper; Birte Y Glenthøj; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-02-23       Impact factor: 7.853

6.  Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.

Authors:  Pejman Sehatpour; Daniel C Javitt; Heloise M De Baun; Marlene Carlson; Anna Beloborodova; David H Margolin; Mark B L Carlton; Nicola L Brice; Joshua T Kantrowitz
Journal:  Neuropsychopharmacology       Date:  2021-10-20       Impact factor: 8.294

7.  Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.

Authors:  Amanda McCleery; Daniel H Mathalon; Jonathan K Wynn; Brian J Roach; Gerhard S Hellemann; Stephen R Marder; Michael F Green
Journal:  Psychol Med       Date:  2019-01-15       Impact factor: 7.723

8.  Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome.

Authors:  Holly K Hamilton; Brian J Roach; Peter M Bachman; Aysenil Belger; Ricardo E Carrion; Erica Duncan; Jason K Johannesen; Gregory A Light; Margaret A Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon; Daniel H Mathalon
Journal:  JAMA Psychiatry       Date:  2019-11-01       Impact factor: 21.596

Review 9.  Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.

Authors:  Holly K Hamilton; Brian J Roach; Daniel H Mathalon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-10-24

10.  Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.

Authors:  Salvatore Campanella; Kemal Arikan; Claudio Babiloni; Michela Balconi; Maurizio Bertollo; Viviana Betti; Luigi Bianchi; Martin Brunovsky; Carla Buttinelli; Silvia Comani; Giorgio Di Lorenzo; Daniel Dumalin; Carles Escera; Andreas Fallgatter; Derek Fisher; Giulia Maria Giordano; Bahar Guntekin; Claudio Imperatori; Ryouhei Ishii; Hendrik Kajosch; Michael Kiang; Eduardo López-Caneda; Pascal Missonnier; Armida Mucci; Sebastian Olbrich; Georges Otte; Andrea Perrottelli; Alessandra Pizzuti; Diego Pinal; Dean Salisbury; Yingying Tang; Paolo Tisei; Jijun Wang; Istvan Winkler; Jiajin Yuan; Oliver Pogarell
Journal:  Clin EEG Neurosci       Date:  2020-09-25       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.